TAG:
in vitro diagnostic
Lab/Path M&A Day Explores High Prices Paid to Lab Owners
IF YOU HAVEN’T NOTICED, there’s a gold rush in diagnostics! Prices paid for clinical laboratories, anatomic pathology group practices, and in vitro diagnostic (IVD) companies have soared recently. This is good news for pathologists and laboratory owners interested in putting their laboratory on …
More Labs Actively Adopt Quality Management
CEO SUMMARY: With almost 300 speakers, attendees, and vendors in attendance from seven countries, Lab Quality Confab was a significant milestone for the global lab industry. On one level, it was a sign that the quality improvement trend has come of age. On another level, it provided ample…
Misys Health Restructures By Selling Two Divisions
CEO SUMMARY: Misys Healthcare Systems of London, England, has sold its diagnostic LIS systems to Vista Equity Partners of San Francisco, California, for $381.5 million. The deal raises several questions, particularly for those labs currently running Misys laboratory information systems (L…
Unprecedented Activity Across Lab Medicine
CEO SUMMARY: Laboratory medicine is now considered one of the best opportunities to profit as the demand for healthcare services skyrockets, both in the United States and throughout the world. This is why a flood of investment capital is washing into the laboratory industry. Loaded with c…
Siemens Acquires Dade, Builds IVD Powerhouse
CEO SUMMARY: In just 15 months, Siemens AG has pulled out its checkbook three times to spend more than $14 billion to acquire major in vitro diagnostics (IVD) companies. When it closes the purchase of Dade Behring, Siemens will be in the first rank of global IVD manufacturers. It has also…
Lean/Six Sigma in Labs Becomes More Common
CEO SUMMARY: Across healthcare, laboratories, hospitals, and health systems are leading the drive to incorporate quality management methods into clinical services and daily operations. This fall, in Atlanta, the Lab Quality Confab will provide a detailed look at this trend, with 50 speake…
GE’s Deal for Abbott IVD Collapses Last Week
CEO SUMMARY: Both companies have said little about their mutual decision, announced last week, to kill the pending sale of Abbott Diagnostics and Point-of-Care businesses to General Electric. One probability is that GE decided, during due diligence, that its willingness to pay a premium p…
Global Laboratory Trends Dominated by Rising Costs and Labor Shortage
“The Web has transformed many industries and it’s clearly affected our industry. This trend will help raise the bar in quality and overall performance among laboratories and manufacturers.” —Jim Reid-Anderson Chairman, President, and CEO of Dade Behring…
Inverness Buys Biosite, Has New Venture with P&G
CEO SUMMARY: On the same day that Inverness Medical Innovations announced that it would acquire Biosite, thus beating out Beckman Coulter in the bidding war for Biosite, Inverness also announced that it had entered into a joint venture with Procter & Gamble. Together, the two companie…
Quest Bites: Will Pay $2 Billion for AmeriPath
CEO SUMMARY: From its inception in the mid-1990s as a pathology physician practice management (PPM) company, AmeriPath was a business that its investors created specifically to be sold. Now Quest Diagnostics Incorporated is stepping up to pay a princely ransom of $2 billion to make AmeriP…
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.